The Critical Edge Podcast Podcast Por The Critical Edge arte de portada

The Critical Edge Podcast

The Critical Edge Podcast

De: The Critical Edge
Escúchala gratis

Welcome to The Critical Edge, the podcast where cutting-edge trauma surgery and critical care research meets clear, actionable insight—curated by a Harvard-trained, AAST-certified trauma surgeon dual-boarded in Surgical Critical Care and General Surgery.

In each episode, we distill the latest high-impact studies, meta-analyses, and guideline updates—from journals like the Journal of Trauma and Acute Care Surgery, Journal of the American College of Surgeons, World Journal of Surgery, and EAST Practice Management Guidelines—into digestible discussions. Whether it's evolving damage control resuscitation strategies, refined whole blood protocols, updated ERATIC (Enhanced Recovery After Trauma and Intensive Care) recommendations, geriatric trauma management, or debates around REBOA and non-operative approaches to solid organ injuries, we break it down with clinical relevance front and center.

No fluff, no filler—just the evidence that matters right now in the OR, ICU, or trauma bay. Perfect for busy surgeons, fellows, residents, APPs, and intensivists who need to stay sharp without wading through stacks of PDFs.

Join us to sharpen your practice with the critical edge that saves lives. New episodes drop regularly—subscribe today and stay ahead of the curve in this fast-moving field.

Please contact us at: thecriticaledgepodcast@gmail.com




The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns.

Copyright 2026 All rights reserved.
Episodios
  • Lit Review: Pediatric Teletrauma, Whole Blood, C-Spines

    Lit Review: Pediatric Teletrauma, Whole Blood, C-Spines
    Apr 7 2026
    Today we examine various strategies to enhance the efficiency and effectiveness of pediatric trauma care. One major focus is a teletrauma pilot program that uses virtual consultations to provide specialist expertise to remote hospitals, successfully reducing unnecessary patient transfers and saving millions in costs. Another study explores the benefits of using whole blood during resuscitation, finding that it lowers total transfusion needs and reduces the time children spend on mechanical ventilation. Additionally, researchers evaluated the PEDSPINE II prediction model, which aims to help clinicians identify cervical spine injuries in infants more accurately to avoid excessive radiation from imaging. Collectively, these articles highlight how telemedicine, optimized blood products, and improved diagnostic algorithms can overcome geographic barriers and clinical uncertainties. Through these innovations, the medical community seeks to provide more precise, resource-efficient treatment for injured children. The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Pediatric Teletrauma, Whole Blood, C-Spines Comprehensive Study Guide This study guide synthesizes current research regarding pediatric trauma management, specifically focusing on the implementation of teletrauma programs, advancements in hemostatic resuscitation using whole blood, and refined clinical prediction models for cervical spine injuries in young children. I. Pediatric Teletrauma Programs and Geographic Access Trauma remains the leading cause of death among children in the United States. While specialized Pediatric Trauma Centers (PTCs) significantly reduce mortality, geographic constraints prevent many children from accessing these facilities. Teletrauma programs have emerged as a solution to bridge this gap. Program Overview and Objectives A pilot teletrauma program was instituted in 2019 at a Level 1 PTC in collaboration with a Statewide Pediatric Trauma Network. The program aims to: Improve Access: Provide specialist evaluation to children in remote or non-specialized hospitals.Timely Assessment: Utilize phone and video consultations to provide immediate recommendations on patient management and disposition.Limit Transfers: Reduce unnecessary "avoidable transfers"—defined as patients admitted for less than 36 hours without receiving major interventions or imaging. Implementation and Clinical Workflow The program provides triage guidelines to Partnering Hospitals (PHs) to aid in the initial evaluation of hemodynamically stable pediatric trauma patients (under 18 years of age). Consultation: The PTC trauma team provides real-time recommendations regarding the need for transfer, specific treatments, and follow-up care.Quality Assurance: Daily virtual rounding by the PTC trauma team ensures the quality of care for patients managed at PHs.Expansion: Between 2019 and 2023, the number of PHs grew from 2 to 32, spanning five states and reaching distances up to 554 miles from the PTC. Key Outcomes and Statistical Data A retrospective study of 151 teletrauma consults revealed the following: Disposition Recommendations: Following consultation, 34% of patients were discharged, 29% were admitted to the local PH, and 35% were transferred to the PTC.Transfer Avoidance: Transfer was avoided in approximately 63–64% of cases.Safety: Only 3% of patients initially recommended for local management required subsequent transfer to the PTC due to worsening conditions (e.g., changing neurological exams in TBI or worsening abdominal pain). No major complications or deaths occurred in the teletrauma cohort.Economic Impact: The program resulted in an estimated savings of $4.3 million due to avoided transfers, with $3.1 million saved in transportation costs alone. -------------------------------------------------------------------------------- II. Whole Blood Hemostatic Resuscitation In cases of severe pediatric trauma involving hemorrhage, early and balanced blood product resuscitation is critical. Traditionally, this involves Component Therapy (CT), but research is increasingly exploring the benefits of Whole Blood (WB). The Shift from Component Therapy to Whole Blood Component therapy involves administering separate units of packed red blood cells (PRBCs), plasma, and platelets. Whole blood offers a single-donor product that simplifies the resuscitation process. Advantages of Whole Blood (WB-CT) over Component Therapy (CT): Reduced Volume and Exposure: Patients receiving WB require lower total volumes of blood products at both 4-hour and 24-hour intervals. This decreases exposure to multiple donors and associated risks, such ...
    Más Menos
    59 m
  • Stopping Post-Trauma VTE

    Stopping Post-Trauma VTE
    Apr 7 2026
    Today we present a clinical review of venous thromboembolism (VTE) management within the high-risk trauma population. It highlights that acute injury creates a dangerous hypercoagulable state, necessitating a careful balance between anticoagulant prophylaxis and the risk of exacerbating active bleeding. The authors emphasize that low-molecular-weight heparin is the preferred pharmacological defense, while mechanical methods like compression devices serve as vital adjuncts when medication is contraindicated. Significant updates are noted regarding the declining use of vena cava filters, which are now reserved for very specific, narrow indications. Special attention is given to the challenges of treating patients with traumatic brain injuries, spinal cord trauma, and obesity, where standard dosing algorithms often fail. Ultimately, the source advocates for multidisciplinary decision-making and vigilant long-term care to reduce the high socioeconomic and physical costs of VTE. The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Stopping Post-Trauma VTE Comprehensive Study Guide Venous thromboembolism (VTE) represents a significant clinical challenge in the management of injured patients, requiring complex decision-making regarding prevention, diagnosis, and long-term therapy. This guide synthesizes the pathophysiology, prophylaxis strategies, diagnostic standards, and specialized treatment protocols for VTE within the trauma population. Pathophysiology and Incidence The prevalence of VTE in trauma patients is driven by the convergence of all three elements of Virchow’s triad: stasis, endothelial injury, and a hypercoagulable state. Virchow’s Triad in Trauma: Stasis: Results from total body immobility or the immobilization of specific injured extremities. This is particularly pronounced in intensive care units, especially among patients requiring neuromuscular blockade.Endothelial Injury: Occurs through direct vascular insult, hemorrhage, or mechanical stresses such as stretch, compression, and crush injuries. Shear stress from cavitation in gunshot wounds can cause intimal injury even without disrupting the vein.Hypercoagulability: Posttraumatic cytokine release activates procoagulant factors while reducing anticoagulant factors. Thrombus formation can begin within minutes of the initial trauma as the body attempts to achieve hemostasis. Incidence Rates: Acute trauma requiring hospitalization is an independent risk factor for VTE, with a hazard ratio of 4.6. Without prophylaxis, venous thrombosis occurs in up to 58% of injured patients, and pulmonary embolism (PE) occurs in up to 11%. Notably, 98% of these thromboses are initially asymptomatic.High-Risk Categories: The highest incidences of VTE are found in patients with lower extremity fractures (69%), spinal cord injuries (62%), and traumatic brain injuries (54%). Other contributing factors include older age, blood transfusions, and surgical interventions.Mortality: Fatal PE accounts for 12% of all deaths following major trauma. A significant portion of symptomatic PEs (37%) occur within the first four days post-injury. Prevention and Prophylaxis Prevention is the cornerstone of VTE management, though it remains controversial due to the competing risk of hemorrhage in trauma patients. Pharmacologic Prophylaxis (Chemoprophylaxis) Low-molecular-weight heparin (LMWH), such as enoxaparin or dalteparin, and low-dose unfractionated heparin (LDUH) are the primary modalities. LMWH vs. LDUH: Historically, LDUH was considered inferior. However, current guidelines suggest that if LDUH is administered every 8 hours (rather than every 12), it is equal in efficacy to LMWH. LDUH is preferred for patients with low creatinine clearance (less than 20 to 30 mL/minute).Standard Dosing: Enoxaparin is typically dosed at 30 mg subcutaneously twice daily or 40 mg daily. For patients exceeding 150 kg, the dose is often increased to 40 mg twice daily.Challenges to Efficacy: Missed doses are a major independent risk factor for DVT formation. While anti-Xa guided dosing has been explored to ensure adequate levels, evidence is mixed on whether it effectively reduces VTE rates. Nonpharmacologic Prophylaxis Mechanical modalities are used when anticoagulants are contraindicated or as an adjunct to chemoprophylaxis. Intermittent Pneumatic Compression (IPC): These devices address stasis and contribute to fibrinolysis. Their efficacy is entirely dependent on patient compliance.Graded Compression Stockings (TED hose) and Foot Pumps: These are used when lower-extremity injuries (like casts or external fixators) prevent the use of IPCs.Ambulation: Early mobility...
    Más Menos
    58 m
  • Targeted Resuscitation with TEG & ROTEM

    Targeted Resuscitation with TEG & ROTEM
    Apr 6 2026
    Viscoelastic testing, specifically through thromboelastography (TEG) and rotational thromboelastometry (ROTEM), has transformed how clinicians manage life-threatening bleeding in trauma victims. Unlike traditional lab tests that only analyze isolated blood components, these tools provide a real-time, comprehensive view of how whole blood forms and dissolves clots. By offering immediate data on clotting strength and speed, these technologies allow for precision-guided resuscitations that utilize specific blood products rather than generic protocols. Research indicates that using these methods reduces mortality rates and prevents the unnecessary use of transfusions by accurately identifying coagulation abnormalities. Furthermore, these diagnostics help doctors predict secondary risks, such as excessive clot breakdown or the potential for dangerous blood clots after the initial injury. Ultimately, integrating these advanced monitoring systems into damage control resuscitation is essential for improving survival outcomes in both military and civilian trauma settings. The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Targeted Resuscitation with TEG & ROTEM Comprehensive Study Guide This study guide provides a comprehensive overview of the role of viscoelastic testing—specifically Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)—in the identification and management of Trauma-Induced Coagulopathy (TIC). It synthesizes historical context, mechanical principles, clinical applications, and the shift from conventional testing to real-time, whole-blood analysis. Overview of Trauma-Induced Coagulopathy (TIC) Hemorrhage remains the primary cause of death in trauma patients. The "fatal triad" of hypothermia, acidosis, and trauma-induced coagulopathy (TIC) significantly worsens patient outcomes. Historically, clinicians relied on conventional coagulation tests (CCT) to manage these patients, but these methods often prove insufficient in the acute setting. Modern management relies on Damage Control Resuscitation (DCR), a strategy focusing on balanced resuscitation, permissive hypotension, the use of whole blood, and hemostatic adjuncts. Viscoelastic testing is a cornerstone of DCR, providing rapid, real-time data to guide blood product administration. Historical Evolution of Viscoelastic Testing The field of viscoelastic testing has evolved from a research tool to a clinical standard in trauma care: Origins: Hellmut Hartert first described TEG at the University of Heidelberg in 1948.Clinical Integration: It was initially adopted in the 1960s for liver transplantations to identify hyperfibrinolysis and in the 1980s for cardiac surgery to manage anticoagulation and bleeding.Application to Trauma: In 1997, Kaufmann et al. demonstrated the utility of TEG in trauma, showing it could predict transfusion needs and define coagulation abnormalities earlier than other methods.Military and Civilian Expansion: Since 2001, military conflicts have accelerated knowledge regarding the resuscitation of injured soldiers. These advancements have been transferred to civilian trauma centers, leading to the widespread adoption of TEG and ROTEM. Testing Mechanics and Modalities Rotational Thromboelastometry (ROTEM) ROTEM is a point-of-care analyzer that tests the hemostatic profile of whole blood. It functions by placing a blood sample in a cup with an oscillating sensor pin. As a clot forms, it restricts the pin's rotation, and this resistance is converted into a graphical display. ROTEM utilizes five specific assays to evaluate different pathways: INTEM: Uses ellagic acid to activate the intrinsic pathway. It is sensitive to factors I, II, and VII through XII, as well as von Willebrand factor.EXTEM: Uses tissue factor/thromboplastin to activate the extrinsic pathway. It is highly sensitive to fibrinolysis and evaluates factors II, VII, IX, and X.FIBTEM: An EXTEM-based assay that adds cytochalasin D to inhibit platelets. This isolates the role of fibrin polymerization in clot formation.HEPTEM: An INTEM-based assay that adds heparinase to neutralize heparin, allowing for the assessment of the underlying coagulation status in heparinized patients.APTEM: An EXTEM-based assay that adds aprotinin to inhibit fibrinolysis. Comparing APTEM to EXTEM helps confirm true hyperfibrinolysis. Thromboelastography (TEG) TEG uses a similar principle but often involves an oscillating cup and a stationary pin. The standard TEG uses kaolin to activate the coagulation cascade. Rapid TEG (r-TEG): This variant adds tissue factor in addition to kaolin, significantly accelerating the activation process and ...
    Más Menos
    36 m
Todavía no hay opiniones